1. Fluoroquinolone-related depression and suicidal ideation

   News item 14 October 2023 Pages: 1 - 1

2. Hospira recalls injection products due to potential glass particulates

   News item 14 October 2023 Pages: 2 - 2

3. Immune checkpoint inhibitor-related aplastic anaemia

   News item 14 October 2023 Pages: 3 - 3

4. ION and Restore nasal sprays recalled due to bacterial contamination

   News item 14 October 2023 Pages: 4 - 4

5. No new AEs after vaccinations in Netherlands national program

   News item 14 October 2023 Pages: 5 - 5

6. One lot of betaxolol recalled due to possible oxycodone tablets in bottle

   News item 14 October 2023 Pages: 6 - 6

7. Poppers pose potentially fatal health risks

   News item 14 October 2023 Pages: 7 - 7

8. PRAC meeting highlights September 2023

   News item 14 October 2023 Pages: 8 - 8

9. Probiotics formulated to contain live bacteria or yeast: risk of invasive disease in preterm infants

   Media release 14 October 2023 Pages: 9 - 9

10. Reports of myasthenia gravis with statin use

    News item 14 October 2023 Pages: 10 - 10

11. Increased anticholinergic burden increases risk of acute cardiovascular events

    Clinical study 14 October 2023 Pages: 11 - 11

12. Use of GLP-1 agonists for weight loss increases risk of GI AEs

    Clinical study 14 October 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 14 October 2023 Pages: 13 - 13

14. Abemaciclib

    Case report 14 October 2023 Pages: 14 - 14

15. Acarbose

    Case report 14 October 2023 Pages: 15 - 15

16. Acetazolamide

    Case report 14 October 2023 Pages: 16 - 16

17. Aciclovir

    Case report 14 October 2023 Pages: 17 - 17

18. Adalimumab

    Case report 14 October 2023 Pages: 18 - 18

19. Adenosine

    Case report 14 October 2023 Pages: 19 - 19

20. Albendazole/praziquantel

    Case report 14 October 2023 Pages: 20 - 20

21. Allopurinol

    Case report 14 October 2023 Pages: 21 - 21

22. Allopurinol/benzathine-benzylpenicillin/meloxicam

    Case report 14 October 2023 Pages: 22 - 22

23. Aluminium-chloride/botulinum-toxin/cholinergic-receptor-antagonists

    Case report 14 October 2023 Pages: 23 - 23

24. Amfetamine/dexamfetamine/methadone

    Case report 14 October 2023 Pages: 24 - 24

25. Aminophylline/salbutamol

    Case report 14 October 2023 Pages: 25 - 25

26. Amiodarone/bupropion

    Case report 14 October 2023 Pages: 26 - 26

27. Amiodarone/iopromide/sotalol

    Case report 14 October 2023 Pages: 27 - 27

28. Amlodipine/azilsartan/dapagliflozin/metformin

    Case report 14 October 2023 Pages: 28 - 28

29. Amlodipine/lisinopril overdose

    Case report 14 October 2023 Pages: 29 - 29

30. Amoxicillin

    Case report 14 October 2023 Pages: 30 - 30

31. Amoxicillin/ceftriaxone

    Case report 14 October 2023 Pages: 31 - 31

32. Amoxicillin/clavulanic-acid/ceftriaxone

    Case report 14 October 2023 Pages: 32 - 32

33. Amphotericin-B-liposomal

    Case report 14 October 2023 Pages: 33 - 33

34. Amphotericin-B/cotrimoxazole

    Case report 14 October 2023 Pages: 34 - 34

35. Amphotericin-b/dexamethasone

    Case report 14 October 2023 Pages: 35 - 35

36. Ampicillin/sulbactam

    Case report 14 October 2023 Pages: 36 - 36

37. Amygdalin

    Case report 14 October 2023 Pages: 37 - 37

38. Anakinra

    Case report 14 October 2023 Pages: 38 - 38

39. Anamorelin/gemcitabine

    Case report 14 October 2023 Pages: 39 - 39

40. Anti-inflammatories

    Case report 14 October 2023 Pages: 40 - 40

41. Anti-inflammatories/immunosuppressants

    Case report 14 October 2023 Pages: 41 - 41

42. Antiasthmatics/umeclidinium

    Case report 14 October 2023 Pages: 42 - 42

43. Antibacterials/micafungin

    Case report 14 October 2023 Pages: 43 - 43

44. Antibacterials/micafungin/norepinephrine

    Case report 14 October 2023 Pages: 44 - 44

45. Antiepileptic-drugs

    Case report 14 October 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 14 October 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 14 October 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 14 October 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 14 October 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 14 October 2023 Pages: 50 - 50